Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at AACR Annual Meeting 2024

Page View:


Join Medicilon at the AACR Annual Meeting 2024
The AACR Annual Meeting is a premier gathering for cancer researchers, where groundbreaking advances in cancer science and medicine are shared. Medicilon is thrilled to exhibit at this crucial event.

Medicilon: Your One-Stop R&D Partner
As a leading integrated CRO, Medicilon offers comprehensive drug discovery services for pharmaceutical and research institutions worldwide. By the end of 2023, we've served over 2,000 clients globally, with 300+ INDs approved in China and 80+ overseas.

Unparalleled Expertise in Immuno-Oncology
Medicilon boasts over 370 tumor evaluation models. We're at the forefront of immuno-oncology research, actively supporting the evaluation and development of innovative therapies like CAR-T, TCR-T, and more.

Date: April 5-10, 2024
Location: San Diego Convention Center, San Diego, California
Medicilon Booth #4021

Meet Dr. Qingcong Lin, President of Medicilon USA Corp. 
Dr. Lin brings nearly 40 years of experience in pharmaceutical R&D, making significant contributions to both academia and the global industry. Visit him at Medicilon booth #4021 to discuss your research needs.


Meet Dr. Wenjie Li, Vice President of the CMC Unit at Medicilon

With nearly three decades in pharmaceutical R&D management, Dr. Li has deep expertise in drug development, including CMC services and CRO/CDMO management, accumulating rich experience and profound knowledge.


Meet with Medicilon
Subject丨AACR Annual Meeting 2024

Relevant newsRelevant news